RUNX3 and lung carcinoma: Recently, we have found for the first time that RUNX3 knockdown significantly attenuates ADR-mediated apoptotic cell death in p53-proficient U2OS and human lung carcinoma A549 cells but not in p53-deficient human lung carcinoma H1299 and human osteosarcoma SAOS-2 cells [118].